Cargando…

Detection of Exosomal PD-L1 RNA in Saliva of Patients With Periodontitis

Periodontitis is the most prevalent inflammatory disease of the periodontium, and is related to oral and systemic health. Exosomes are emerging as non-invasive biomarker for liquid biopsy. We here evaluated the levels of programmed death-ligand 1 (PD-L1) mRNA in salivary exosomes from patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jialiang, Lin, Yusheng, Xiong, Xiao, Li, Kai, Yao, Zhimeng, Dong, Hongmei, Jiang, Zuojie, Yu, Dan, Yeung, Sai-Ching Jim, Zhang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426748/ https://www.ncbi.nlm.nih.gov/pubmed/30923536 http://dx.doi.org/10.3389/fgene.2019.00202

Ejemplares similares

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study
por: Li, Kai, et al.
Publicado: (2022)

DNA Methylation Biomarkers Predict Objective Responses to PD-1/PD-L1 Inhibition Blockade
por: Xue, Gang, et al.
Publicado: (2019)

Plasma- and Saliva Exosome Profile Reveals a Distinct MicroRNA Signature in Chronic Periodontitis
por: Nik Mohamed Kamal, Nik Nur Syazana, et al.
Publicado: (2020)

Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer
por: Xu, Yajing, et al.
Publicado: (2021)

Noncoding RNAs in human saliva as potential disease biomarkers
por: Lin, Xianzhi, et al.
Publicado: (2015)

Protein Biomarkers of Periodontitis in Saliva
por: Taylor, John J.
Publicado: (2014)

The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma
por: Cheng, Yong, et al.
Publicado: (2021)

Complement split product C3c in saliva as biomarker for periodontitis and response to periodontal treatment
por: Grande, Maria Anastasia, et al.
Publicado: (2020)

MeImmS: Predict Clinical Benefit of Anti-PD-1/PD-L1 Treatments Based on DNA Methylation in Non-small Cell Lung Cancer
por: Shang, Shipeng, et al.
Publicado: (2021)

Identification of Crucial Gene Modules Related to the Efficiency of Anti-PD-1/PD-L1 Therapy and Comprehensive Analyses of a Novel Signature Based on These Modules
por: Wang, Wei, et al.
Publicado: (2022)

Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response
por: Chen, Gang, et al.
Publicado: (2018)

Grading system for periodontitis by analyzing levels of periodontal pathogens in saliva
por: Kim, Eun-Hye, et al.
Publicado: (2018)

Translational and Clinical Applications of Dental Stem Cell-Derived Exosomes
por: Mai, Zizhao, et al.
Publicado: (2021)

Neoantigen‐based cancer vaccination using chimeric RNA‐loaded dendritic cell‐derived extracellular vesicles
por: Xiong, Xiao, et al.
Publicado: (2022)

Research progress of exosomes in orthopedics
por: Zhang, Liang, et al.
Publicado: (2022)

“Exosomics”—A Review of Biophysics, Biology and Biochemistry of Exosomes With a Focus on Human Breast Milk
por: de la Torre Gomez, Carolina, et al.
Publicado: (2018)

Progress in research on the role of exosomal miRNAs in the diagnosis and treatment of cardiovascular diseases
por: Xu, Jinyu, et al.
Publicado: (2022)

Clinical Significance of Serum-Derived Exosomal LINC00917 in Patients With Non-Small Cell Lung Cancer
por: Xiong, Dani, et al.
Publicado: (2021)

Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
por: Borch, Annie, et al.
Publicado: (2023)

Comparative analyses of salivary exosomal miRNAs for patients with or without lung cancer
por: Liu, Mengfeng, et al.
Publicado: (2023)

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
por: Tang, Yanyan, et al.
Publicado: (2020)

The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma
por: Wang, Lu, et al.
Publicado: (2018)

Saliva: A diagnostic biomarker of periodontal diseases
por: Patil, Priti Basgauda, et al.
Publicado: (2011)

Periostin levels in saliva of patients with chronic periodontitis
por: Esfahrood, Zeinab Rezaei, et al.
Publicado: (2018)

Saliva and Serum Immune Responses in Apical Periodontitis
por: Pietiäinen, Milla, et al.
Publicado: (2019)

The role of exosomal PD-L1 in tumor immunotherapy
por: Wang, Jing, et al.
Publicado: (2021)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

Metagenomic Analysis of Saliva Reveals Disease-Associated Microbiotas in Patients With Periodontitis and Crohn’s Disease-Associated Periodontitis
por: Sun, Boyang, et al.
Publicado: (2021)

Exosomal miRNAs as Biomarkers for Prostate Cancer
por: Hessvik, Nina Pettersen, et al.
Publicado: (2013)

Exosome-Derived microRNA: Efficacy in Cancer
por: Padda, Jaskamal, et al.
Publicado: (2021)

The role of milk-derived exosomes in the treatment of diseases
por: Rashidi, Mehdi, et al.
Publicado: (2022)

Potential Networks Regulated by MSCs in Acute-On-Chronic Liver Failure: Exosomal miRNAs and Intracellular Target Genes
por: Zhang, Jing, et al.
Publicado: (2021)

Exploration of Shared Gene Signatures and Molecular Mechanisms Between Periodontitis and Nonalcoholic Fatty Liver Disease
por: Xu, Wanqiu, et al.
Publicado: (2022)

Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance
por: Vautrot, Valentin, et al.
Publicado: (2021)

Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling
por: Wang, Lu, et al.
Publicado: (2021)

Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling
por: Wang, Lu, et al.
Publicado: (2021)

Non-Invasive microRNA Profiling in Saliva can Serve as a Biomarker of Alcohol Exposure and Its Effects in Humans
por: Mead, Edward A., et al.
Publicado: (2022)

Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer
por: Tang, Shuli, et al.
Publicado: (2020)

Exosomal miRNAs: Biological Properties and Therapeutic Potential
por: Hu, Guoku, et al.
Publicado: (2012)

A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules
por: Liang, Meihua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o4p5hkl9u2fnn361lk1sb6deer